Second US Patient on FSGS Trial
April 7th 2021
We are excited to have our first patient on an exciting new therapy for FSGS
Notice: Prolato’s official email domain is @prolato.org. Any other domains are not affiliated with us.
April 7th 2021
We are excited to have our first patient on an exciting new therapy for FSGS